Fig. 3From: Docking and ADMET studies for investigating the anticancer potency of Moscatilin on APC10/DOC1 and PKM2 against five clinical drugsInteraction of ligands with target protein APC10/DOC1 (IJHJ). Docked positions of ligands (color — light green), generated by PyMOL. The ligands used were a Moscatilin, b Resveratrol, c Mitomycin-C, d Colchicine, e Paclitaxel, and f ShikoninBack to article page